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We designed a protocol to identify cell surface molecules 
expressed in restricted spatial patterns in the developing 
central nervous system (CNS) that might be regulated by 
regionally restricted transcription factors. The immunogen 
was a membrane fraction from NT2/D1 embryocarcinoma 
cells that were induced to differentiate into neurons and 
upregulate Hox gene expression in response to retinoic 
acid. One monoclonal antibody (mAb), FORSE-1, specifi-
cally labels the rostral rat CNS from the earliest stages. 
Staining is observed in the rostral but not caudal neural 
folds of the embryo prior to neural tube closure. Staining 
Is enriched in the forebrain as compared to the rest of the 
CNS, until E18. Between E11.5 and E13.5, only certain ar-
eas of the telencephalon and dlencephalon are labeled. Lat-
er, up to E17.5, FORSE-1 labeling Is specifically restricted 
to the telencephalon, where a correlation with mitotic ac-
tivity is apparent: the ventricular zone labels with FORSE-
1, while the cortical plate is negative. The staining of the 
neuroeplthelium is intensified by acetone fixation, which 
also reveals, between E11.5 and E13.5, a dorsoventrally re-
stricted, FORSE-1-positive region of the spinal cord. After 
E18, the entire CNS is labeled, through adulthood. The mAb 
labels the surfaces of dissociated, living cells. Other, non-
CNS areas of FORSE-1 labeling are nasal and otic placo-
des, nasal epithelium, nasal glands, and early (E9.5-10.5) 
endoderm. mAb FORSE-1 recognizes an epitope present 
on both a high-molecular-weight (>200 kDa) proteoglycan 
from embryonic and early postnatal brain, and on a 80 kDa 
doublet that is restricted to the CNS In the adult. 
These findings suggest the FORSE-1 antigen as a can-
didate cell surface molecule for mediating regional speci-
fication from the earliest stages of CNS development. 
[Key words: forebrain, cyclophosphamide immunosup-
pression, dorsoventral, position, proteoglycan, NT21D1, 
rostrocaudal] 
The development of the vertebrate CNS is a complex process 
during which the neural tube gives rise to a variety of divergent 
neural structures. A critical issue is how these differences are 
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generated. In the hindbrain, for example, the positions of the 
transient folds of the rhombomeres are correlated with the rostral 
limits of expression of several HoxB genes (Krumlauf et al., 
1987; Graham et al., 1988; Hogan et al., 1988; Schughart et al., 
1988; Bogarad et al., 1989; Frohman et al., 1990; Vogels et al., 
1990; Hunt et al., 1991) as well as Hox A and D genes (Krum-
lauf, 1993). The spatial overlap of these genes suggested a role 
in defining axial position and cell identity, and disruption of Hox 
gene expression leads to alterations in cell migration and fate 
(Chisaka and Cappechi, 1991; Lufkin et al., 1991; Chisaka et 
al., 1992). Limited information is available concerning candidate 
downstream molecules. Hox 2.4 and 2.5 differentially regulate, 
in vitro, a construct containing the promotor of NCAM (Jones 
et al., 1992), and the highly polysialated form of NCAM is en-
riched at rhombomere boundaries (Lumsden and Keynes, 1989). 
Antigens bearing the HNK-1 epitope are also specifically present 
in odd-numbered rhombomeres in the hindbrain (Kuratani, 
1991 ). These and other surface/extracellular molecules could 
play a role in giving each rhombomere a unique identity. 
Regional specification of the developing forebrain, in contrast, 
is complicated by the fact that different areas have very diverse 
architectonic characteristics. In the mammalian forebrain, the ol-
factory bulb consists of three-layered paleocortex; in the telen-
cephalon, the medial walls give rise to one-layered archicortex, 
the lateral walls give rise to six-layered neocortex, and the basal 
telencephalon forms the striatum; the diencephalon gives rise to 
thalamic structures. Thus, these various regions may not repre-
sent simple modifications of iterated segmental domains. 
While the Hox genes are not expressed rostral to the hind-
brain, homeobox-containing and other classes of transcription 
factors have recently been found to overlap in interesting pat-
terns in the developing forebrain. BF-1, Dlx-1, Dlx-2, and TTF-1 
are expressed in regions of the olfactory bulb and telencephalon 
(Lazzaro et al., 1990; Porteus et al., 1991; Price et al., 1991; 
Robinson et al., 1991; Tao and Lai, 1992); Dlx-1, Nkx.2.2, and 
TIF-1 demarcate overlapping regions in the diencephalon (Price 
et al., 1992); Otx-1, Otx-2, Emx-1, and Emx-2 are expressed in 
nested domains extending from the forebrain to the hindbrain 
(Simeone et al., 1992); MASH- I is expressed in a subpopulation 
of neural precursors in spatially restricted domains in the CNS 
(Lo et al., 1991). These various patterns are suggestive of a role 
in defining regional identity, and some of their boundaries are 
consistent with proposed rostrocaudal and dorsoventral domains 
in the forebrain (Buffone et al, 1993). Results of functional per-
turbation experiments are not yet available, however, and little 
is known about the downstream targets of these genes. It seems 
likely that critical intercellular interactions in the developing 
forebrain will involve secreted, cell surface, and extracellular 
matrix molecules. 
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Table 1. Injection schedule for Balb/c mice 
Treatment 
Day 1 
Day 2 
Day 3 
Day 8 
Day 14 
Day 22 
Day 23 
Day 26 
300 µg RA(-) plus 0.2 ml RIBI adjuvant (RIBI Immunochem) plus cyclophosphamide (100 mg/kg body weight, i.p.) 
Cyclophosphamide only (i.p.), same dose 
Cyclophosphamide only (i.p.), same dose 
Serum screening 
300 µg RA(+) plus 0.2 ml RIBI adjuvant (i.p.) 
Serum screening 
Boost #2 mouse with 100 µg RA(+) (intrasplenic injection) 
Fuse #2 mouse, 1.65 X 108 spenocytes were collected and fused with 6.2 X 107 HLl-653 myeloma cells (Kohler and 
Milstein, 1975); cells were plated at 2.2 x 105 cells/well 
In order to identify cell surface molecules that are expressed 
in restricted distributions during CNS development and that may 
be responsive to position-specifying transcription factors, we 
generated monoclonal antibodies (mAbs) against the membrane 
fraction of retinoic acid-induced, human embryocarcinoma 
(NT2Dl) cells. In response to retinoic acid, these cells express 
neuronal differentiation markers as well as certain Hox genes 
(Andrews, 1984; Mavilio et al., 1988; Simeone at al., 1990). We 
reasoned that neuronal differentiation, coupled with specific Hox 
gene expression, could result in the production of downstream, 
cell surface antigens with interesting positional distributions. We 
used cyclophosphamide immunosuppression (Matthew and Pat-
terson, 1983; Matthew and Sandrock, 1987; Ou et al., 1991) 
against the membranes of uninduced NT2D 1 cells to bias the 
immune response in favor of novel membrane antigens that are 
induced by retinoic acid treatment. 
One mAb generated from this fusion, FORSE-1 (forebrain-
surface-embryonic), labels the embryonic rat forebrain very spe-
cifically. Within the forebrain, FORSE-1 has a restricted staining 
pattern that demarcates subregions of the telencephalon and di-
encephalon that have not been previously described. In this pa-
per, we describe the immunohistochemical labeling pattern of 
FORSE-1 during development and the biochemical characteriza-
tion of the antigens recognized by the mAb. 
Materials and Methods 
Cell culture. Clone DI of the NTERA-2 (referred to as NT2/Dl) human 
EC cells were obtained from P. W. Andrews (The Wistar Institute of 
Anatomy and Biology). NT2/Dl cells were maintained at high density 
Tl!ble 2. Serum screening results (days 8 and 22) 
Day 8 screen 
Control 
Exp 1 
Exp 2 
Day 22 screen 
Control 
Exp 1 
Exp 2 
1:500 
<1:50 
<1:50 
titer 
1:5000 
1:100 
1:250 
RA 
1:5000 
1:100 
1:500 
titer 
Sera samples were tested against the RA( - ) and/or RA(+) membrane/cyto-
skeletal preparations on dot blots. The control mouse received the antigen in-
jection without cyclophosphamide. For Exp I and Exp 2, experimental mice 
received the antigen injection plus cyclophosphamide. The Exp 2 mouse was 
selected for fusion because it showed a difference in titer against the RA(+) 
versus the RA( - ) preparations. 
in Dulbecco's modified minimal essential medium supplemented with 
10% fetal bovine serum. Cultures to be exposed to retinoic acid (RA) 
were established by plating a trypsinized single-cell suspension of un-
differentiated NT2/D 1 cells at a density of 106 cells per 75 cm2 tissue 
culture flask (Andrews, 1984; Andrews et al., 1984). RA (10 mM so-
lution in dimethyl sulfoxide, all-trans; Sigma Chemicals) was added to 
a final concentration of 10-s M. The medium was changed with fresh 
medium containing RA every 48 hr. Differentiation was monitored by 
morphological changes in the cultures, and by the proportion of cells 
positive for the glycolipid surface marker A2B5 (Andrews et al., 1990). 
The RA-induced immunogen (see below) was generated from cells that 
had been exposed to 10-s M RA for 2 weeks. 
Preparation of the immunogen. Undifferentiated and RA-induced 
NT2/Dl cells were harvested by rolling 3 mm diameter glass beads (P. 
W. Andrews, personal communication) over the surface of confluent 
cell layers in a few milliliters of medium. The intact cells were then 
centrifuged at 1000 rpm for 10 min in an IEC HN-SII tabletop centri-
fuge. The cell pellets were then resuspended in homogenization buffer 
[50 mM Tris-HCI (pH 7.4), 50 mM NaCl, 5 mM EDTA, 2 mM EGTA] 
containing five protease inhibitors: I mM phenylmethylsulfonyl fluoride, 
20 µg/ml aprotinin, 20 µg/ml turkey egg white trypsin inhibitor, 2 mM 
benzamidine, and 5 mM N-ethylmaleimide, and homogenized with a 
Polytron (Brinkman Instruments Co.). The homogenates were centri-
fuged at 1000 rpm, as described above, to remove nuclei and cell debris. 
The resulting supernatants were then centrifuged at 100,000 x g for 1 
hr in a Beckman 70 Ti rotor. The pellets were resuspended in homog-
enization buffer and washed twice by centrifugation at 100,000 X g for 
1 hr and subsequent resuspension. The final pellets were resuspended 
in homogenization buffer. This material, which will be referred to as 
the membrane/cytoskeletal fraction, was either used immediately or fro-
zen at -80°C until further use. All procedures were carried out at 4°C. 
Protein was determined by the method of Lowry et al. (1951) or by the 
BCA protein assay (Pierce Chemical Co.). 
Immunization and mAb production. Balb/c mice were injected with 
either undifferentiated NT2/D 1 membrane/cytoskeletal fractions [RA( - ) ] 
or RA-induced NT2/D I membrane/cytoskeletal fractions [RA(+)] ac-
cording to the schedule described in Tables 1 and 2. The myeloma cells 
used for the fusion were HLI-653 (Taggart and Samloff, 1983). 
Jmmunohistochemistry. Pregnant female Sprague-Dawley rats were 
obtained from Simonsen Laboratories (Gilroy, CA). The morning after 
the day of mating is designated as day 0.5. Whole embryos, embryonic, 
and adult tissues were directly frozen, without fixation in O.C.T. (Tis-
sue-tek), on dry ice. Sections (JO µm) were cut using a Bright cryostat 
(Hacker Instruments, Inc.), and placed on gelatin-coated slides. After 
air drying, the sections were either stained immediately or stored at 
-80°C. Acetone fixation, when performed, was carried out using ace-
tone for 10 min, 0°C, prior to the staining procedure given below. 
The sections were preadsorbed with 2% goat serum in PBS, and 
incubated in primary antibody (hybridoma supernatant) for 1 hr at room 
temperature (RT), washed twice with PBS, and then incubated in the 
secondary antibody that was either FITC conjugated (FITC-goat anti-
mouse IgM, Tago Inc., used at l: 100 in PBS) or biotinylated (Vector 
Mouse IgM ABC-peroxidase kit). In the latter case, the Vector ABC 
procedure was followed without blocking endogenous peroxidase, using 
a negative control (no primary antibody) to assess background staining. 
Cultures were stained live for FORSE-1, similar to the procedure for 
sections, using FITC-labeled secondary antibody. FITC-labeled cultures 
and slides were mounled in glycerol containing n-propyl gallate (8 mg/ 
ml final concentration, dissolved in 0. 1 M Tris-HCI, pH 9). Peroxidase-
labeled slides were mounted in Aquamount (BOH Ltd., Poole, En-
gland). Slides were observed and photographed using a Zeiss ICM 405 
microscope. Kodak Tri-X Pan 400 film was u~ed for fluorescence pic-
tures, and Kodak Plus-X Pan 125 or Kodak Gold 100 film for bright-
field pictures. 
Tissue cufJure. E16 telencephalic lobes were dissected in Ca1+JMg1 • -
free Hanks-A solution, and incubated in I mg/ml collagenase (Wor-
thington Biochemical Corp.) in Hanks-A for I hr at 37°C. The enzyme 
was then blocked by the addition of serum. Cells were washed free of 
collagenase by pelleLing at IOOO rpm in a Labletop centrifuge and re-
suspending in culture medium (repeated twice). Undissociated clumps 
were broken up by gentle trituration using a flame-polished Pasteur 
pipette that had been preadsorbed with serum. Cells were plated on 
polylysine-laminin-ooated tissue culture dishes (Coming, 35 mm). LIS 
C02 medium (Hawrot and Panerson, 1979) supplemented with I 0% 
FBS was used as the tissue culture medium. Cells were cultured for 16 
hr. 
Preparation of tissue fractions. Tissues from various age rat embryos, 
and postnatal and adull rats were dissected and immediately frozen on 
dry ice. The postnatal and adult rats were killed by asphyxiation with 
carbon dioxide. Upon thawing, tissues were homogenized by hand or 
with a Polytron (Brinkman Instruments Co.) in homogenization buffer. 
The homogenates were centrifuged at 1000 rpm for I 0 min to remove 
nuclei and cell debris. The supematants were centrifuged at 100.000 X 
g for I hr. The supernatants resulting from this centrifugation were 
either used immediately or frozen at -80°C, and will be referred to as 
the soluble fractions. Pellets were resuspended in homogenization buffer 
and washed twice by centrifugation at 100,000 x g for l hr. The final 
pellets were resuspended in homogenization buffer. These preparations, 
which will be referred to as the membrane/cytoskeletal fractions, were 
either used immediately or frozen at -80°C. In some cases. the mem-
brane/cytoskeletal fractions were also solubilized in nonionic detergent. 
This was done by first recentrifuging these fractions at 100,000 x g for 
I hr. The pellets were then thoroughly resuspended by homogenization 
in homogenization buffer containing 1% Triton X-100 or NP40, and 
centrifuged again at 100,000 x g for I hr. The resulting supematants 
contain the nonionic detergent-solubilized proteins. 
Enzymatic digestions. Soluble fractions of embryonic, early postnata.l, 
and adult CNS tissues solubilized with 1 % NP40 were directly digested 
with the following glycosida~es: chondroitinase ABC (2.0 U/ml, from 
proteus vulgaris; Sigma), hyaluronidase (500 U/ml, from leeches; Sig-
ma). heparinase I (100 U/ml, from Flavobacterium heparinwn; Sigma), 
keratanase (2.5 U/ml, from pseudomonas species; Sigma), endoglycos-
idase H (0.5 U/ml, recombinant E. coli; Boehringer Mannheim), neur-
aminidase (0.2 U/ml, from Vibrio cholerae; Boehringer Mannheim), and 
N-glycosidase F (4.0 U/ml, from Flavobacterium meningosepticwn; 
Boehringer Mannheim). In each case, approximately 100 µg of protein 
in the homogenization buffer described above (including protease in-
hibitors) was digested for 12- 16 hr at 37°C. As controls, identical pro-
tein samples were treated in exactly the same way, but did not include 
enzyme. At the end of the incubation period all samples were diluted 
I: I with 2X SOS-PAGE reducing sample buffer (20% glycerol, 4% 
sos. 0.13 M Tris. 2% ~-mercaptoethanol, and o.oi bromophenol blue, 
pH 6.8) to terminate the digests. 
Electrophoresis and immunoblotting. One-dimensional SOS-PAGE 
was performed as described by Laemmli ( 1970) in 1.5 mm thick, 7% 
polyacrylamide slab gels. All samples were diluted 1: I with 2X non-
reducing or reducing sample buffer (see above) prior to loading. Non-
reducing sample buffer is identical to reducing sample buffer, but does 
not contain ~-mercaptoethanol. lmrounoblots were performed as de-
scribed by Kaprielian and Patterson (1993), with the modifications listed 
below. First, proteins present within the resolving as well as the stacking 
portions of the gels were routinely transferred to nitrocellulose. Primary 
antibody incubations were for 5 hr at room temperature or 12-16 hr at 
4°C; with either mAb FORSE-1 or mAb 52G9 (undiluted hybridoma 
supernatant). The nitrocellulose filters were incubated with goat anti-
mouse IgM affinity-purified antisera conjugated to peroxidase (Chemi-
con, Int.) and diluted I :200, to detect primary antibody binding. 
Results 
mAb production and screening 
We used the cyclophosphamide immunosuppression method to 
bias the immune response towards membrane antigens on reti -
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Figure 1. FORSE-1 labeling in the E9.5 rat embryo. Sections of E9.5 
rat embryos stained with FORSE-1 show label in the rostral neural folds 
(arrows), while the primitive streak at the caudal end of the embryo is 
unlabeled (A). In addition, the dorsal surface of the entire embryonic 
and extraembryonic ectoderrn (small arrowheads), and the endoderm 
(large arrowheads) labels with FORSE-1. This labeling is also present 
in a more caudal section (B), where the neuroepithelium itself does not 
label (arrows point to neural folds). Scale bar, 200 µm. 
noic acid-induced NT2D l embryocarcinoma cells. Hybridoma 
supematants were screened on frozen, sagittal sections of whole 
El4.5 and El8.5 rat embryos, postfixed with 1% paraformal-
dehyde. This protocol reflects a compromise between the need 
to preserve the integrity of the neural tissue through fixation and 
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Figure 2, FORSE-1 labels the El 2.5 CNS. A-C. A reconstruction of lhe labeling pattern of FORSE-1 in Lhe E 12.5 rat embryo. A, Schematic of 
a lateral view of an El2.5 embryo showing the CNS, and the staining pattern of FORSE- l in the telencephalon (stipple) and diencepbalon (hatches). 
This pauern was reconstructed from serial sections cut as in B. B, A cutaway view of A, showing the plane of sectioning, and a representative 
section after staining with FORSE-1. C. Serial sections of the bead of an El2.5 embryo cut as shown in 8, displayed in order from upper left to 
lower right, stained with FORSE-1 , show labeling vf tlte nasal pits (11µ), 1elcnccpbalon ( t), and diencephalon (d), but not the midbrain (mb) and 
hindbrain (hb). Within the telencephalon. a restricted region of the medial walls remains unlabeled (arrows). and the diencephaloo shows three 
FORSE-1-positive regions (arrowheads) separated by FORSE-1-negative regions. o is the otic placode that shows FORSE-1 staining. The developing 
eye (e) does not label with FORSE- 1. Scale bar, l mm. 
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Figure 3. FORSE-1 labels EIS rat telencephalon. Rows A- D each show serial sections of an EIS rat embryo, through the brain, cut as shown in 
E, stained with cresyl violet, FORSE-1 (unfixed sections), FORSE-1 (acetone-fixed sections), and 52G9. A and 8 show the telencephalon and 
diencephalon (d). In the telencephalon, FORSE-1 staining is present throughout the neuroepithelium, except for the outer region of the basal 
telencephalon (bt). The diencephalon does not label with FORSE-1 at this age. The cochlear ducts (cd) also label with FORSE-1. Acetone fixation 
enhances but does not alter this labeling pattern, except that a greater area of the basal telencephalon shows label, and minor areas of labeling 
appear along the ventricular zone of the diencephalon. S2G9 shows a labeling pattern very similar to FORSE-1, where the telencephalon, but not 
the diencepha.lon, and the cochlear ducts are stained. C shows the telencephalon, diencephalon, and part of the hindbrain (hb), and D shows the 
midbrain (mb) and hindbrain. FORSE-1 does not label the diencephalon, midbrain, or hindbrain, except for label along the midline of the hindbrain. 
The spinal cord does not appear in these sections since the head of the embryo was frozen separate from the body in preparation for sectioning. 
Scale bar, I mm. 
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Figure 4. FORSE-1 labels El7.5 telencephalon. A, B, Serial transverse s.ections of an E17.5 rat brain, stained with cresyl violet (A) and FORSE-1 
(8), showing the lateral wall of the telencephalic bulb, where FORSE-1 labels the ventricular zone (vz) but not the cortical plat.e (cp). Scale bar, 
250 µm. 
a desire to preserve the proteins in their native state for later 
identification and isolation (Patterson, 1992). 
Of 960 hybridomas generated, approximately 640 superna-
tants contained mAbs and were screened on sections. Approxi-
mately half of these did not detectably label the CNS, and most 
of the other half labeled the entire CNS of one or both ages, 
with no positional differences in intensity. mAb FORSE-1 was 
selected for further study because it intensely labels the El4.5 
forebrain, while the rest of the CNS appears negative. 
FORSE-1 labeling in the CNS: forebrain, midbrain, hindbrain, 
and spinal cord 
In rat embryos, FORSE-1 binding is detected as early as E9.5, 
labeling the rostral but not the caudal neural folds (Fig. l). In 
addition, the dorsal surface of the entire embryonic ectoderm, 
and the endoderm label with FORSE-1. At El0.5, the prosen-
cephalon, but not the relJlainder of the CNS, labels with 
FORSE-1 (not shown). The pharyngeal arches, Rathke's pouch, 
and gut label as well (not shown). 
From El 1.5 to El3.5, telencephalic and diencephalic staining 
Figure 5. FORSE-1 labels freshly dissociated and cultured telence-
phalic cells. El 6 telencephalic cells, freshly dissociated (B) or cultured 
for 16 hr (D), stained live with FORSE-1 show label on the surfaces 
of the cells. A, C, Phase-contrast photographs corresponding to B and 
D, respectively. Scale bar, 10 µ.m. 
is clear (Fig. 2C). As summarized in a reconstruction of serial 
sections, restricted areas of these structures are FORSE-1 neg-
ative (Fig. 28). The neuroepithelium is almost entirely prolif-
erative at these stages, and hence has no distinguishable layers. 
The medial walls of most of the telencephalic bulbs are negative, 
while the rest of the telencephalon is positive, with the basal 
telencephalon (the ventral region of the telencephalic bulbs) be-
ing most intensely labeled. In addition, at these stages there ap-
pears to be a rostrocaudal gradient in the labeling of the lateral 
walls of the telencephalic vesicles where the rostralmost regions 
label less intensely than the caudal areas. In the diencephalon, 
there are discrete FORSE-1 -positive areas separated by FORSE-
1-negative areas (Fig. 2C). The midbrain and hindbrain are 
sometimes weakly labeled at these stages, while the cord is con-
sistently negative. Weak midbrain- hindbrain labeling is de-
scribed under the later section on acetone fixation. 
At El 5, labeling is further restricted such that FORSE-1 bind-
ing in the telencephalon is maintained, with the basal telenceph-
alon being most intensely labeled, while the diencephalon is 
FORSE-1 negative (Fig. 3). This contrasts with the pattern at 
earlier stages where both the telencephalon and the diencepbalon 
are strongly labeled. The lateral and dorsal telencephalon dis-
plays label throughout the neuroepithelium. The basal telen-
cephalon shows the most intense FORSE-1 label, but this label 
is in the ventricular and adjacent regions, while the outer region 
containing fibers and postrnitotic cells is negative. The rest of 
the CNS is negative, except for labeling along the midline of 
the hindbrain (Fig. 3). 
At E 17 .5, the rostrocaudal restriction of l;'ORSE-1 labeling is 
simiJar to that at E 15 in that only the telencephalon labels while 
the rest of the CNS is negative. Within the telencephalon, 
FORSE- 1 now labels only the ventricular zone of dividing cells, 
while the cortical plate, where postmitotic neurons accumulate, 
is negative (Fig. 4). FORSE-1 labeling is seen on live, intact 
cells from the embryonic telencephalon, demonstrating that the 
antigen is on the cell surface (Fig. 5) .. 
The olfactory bulb is FORSE- I positive in the glomerular 
layer from El7.5 through postnatal life. The staining appears to 
be around the glomeruli, where the periglomerular cells, mitral 
cells, and interstitial tufted cells are located, and not within the 
glomeruli, where olfactory sensory axons make their synapses 
(Fig. 6A- D). By Pl 0, this glomerular layer labeling is much 
A c E 
gl 
D F 
ob 
i 
I 
9. 
Figure 6. FORSE- l labels embryonic rat olfactory bulb and nasal cavity. A and B, C and D, and E and F, Serial transverse sections of an E2 I rat embryo, stained with FORSE-1 (A, C. E) I 
and methyl green (B, D, F). A shows FORSE-1 label in the glomerular layer of the olfactory bulb (ob) and in the olfactory epithelium (oe), while other areas of the olfactory bulb, the nasal · 
cavity, and the retina (r), visualized in B, are unlabeled. C is a higher magnification of the olfactory bulb, showing that the FORSE- 1 label is in the glomerular layer of the olfactory bulb (gl), 
around the glomeruli , where the periglomerular cells and interstitial tufted cells are located, and not within the glomeruli where olfactory axons make their synapses. Other areas of the olfactory -.,, 
bulb visualized in Dare unlabeled. E shows the FORSE-l label in the mucus lining of the nasal epithelium, while there is reduced label within the epithelium itself. Scale bars: 0.5 mm for A g 
and B; 100 µm for C and D; JO µ m for£ and F. ! 
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Figure 7. Effect of acetone fix.ation 
on FORSE-1 staining. Sections of 
El2.5 embryos through the forebrain 
(jb), hindbrain (hb) (A. C, E, G), and 
spinal cord (sc) (8, D, F, H) were la-
beled with cresyl violet (A, B), 
FORSE-1 , no fixation ( C, D), diluted 
FORSE-1, acetone fixation (£, F), and 
FORSE-1, acetone fixation (G, H). On 
unfixed sections (C, D), FORSE-1 la-
bels only the forebrain, and not the 
hindbrain or spinal cord. Acetone fix-
ation (G, H) reveals label in the dorsal 
part of the midbrain and spinal cord, as 
well as an intensified staining of the 
forebrain . However, if acetone-fixed 
sections are labeled with diluted 
FORSE-1 (E, F), the staining is essen-
tially identical to C and D, where only 
the forebrain is labeled. Scale bars: top 
row, I mm; bottom row, 0.5 mm. 
B 
sc[ 
weaker. In the adult, the entire bulb is very weakly stained (not 
shown). 
After El8.5, the FORSE-1 labeling pattern changes to one 
where many neurons in the CNS (except for the olfactory bulb, 
described above) are positive (not shown). This pattern remains 
into maturity. In the adult, the entire CNS has weak, patchy 
FORSE-1 labeling in the gray matter (not shown). 
FORSE-1 labeling in sensory structures 
The nasal pits are FORSE-1 positive from El 1.5 through E14.5. 
At El5.5, the nasal epithelium, now thrown into folds, is 
FORSE-1 positive and continues to be so until birth, with bind-
ing mainly on the surface of the epithelium, lining the cavity, 
and to a lesser degree within the sensory epithelium itself (Fig. 
6E,F). Other nasal tissues, the lateral nasal, septa!, and vome-
ronasal glands, are FORSE-1 positive from El 7 .5 through PIO 
(not shown). The vomeronasal organ itself is negative at all ages 
(not shown). 
The retina is FORSE-1 positive upon acetone fixation, from 
El 1.5 to El 5 (not shown), but subsequently becomes negative 
until birth, when the inner nuclear layer of the retina is FORSE-1 
positive. This staining continues in the adult (not shown). 
The otic placodes are FORSE-1 positive from El0.5 onward 
(El2.5, Fig. 2C). From E15 to El7.5, the cochlear ducts stain 
with FORSE-1, primarily on the inner surface (Fig. 3). At birth, 
no labeling of otic structures is detected (not shown). 
Effect of acetone fixation on FORSE-1 labeling 
The FORSE-1 epitope is sensitive to paraformaldehyde, ethanol, 
and methanol fixation, therefore all of the data described above 
is from fresh-frozen sections, either unfixed or postfixed in 1 % 
paraformaldehyde. Postfixation in acetone (I 0 min, 0°C or 
-20°C) remarkably intensifies the staining in areas that are 
FORSE-1 positive, while background staining (no 1° antibody 
or irrelevant IgM 1° antibody) remains very light (Figs. 3, 7). 
The ability of acetone to increase the sensitivity of staining by 
the FORSE-1 antibody was tested using various dilutions of 
FORSE-1 supernatant on acetone-fixed sections, described be-
low. In addition, we determined, using dissociated cells, that the 
subcellular localization of the staining with and without acetone 
fixation was similar; that is, acetone-fixed, dissociated E l5 tel-
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encephalic cells appeared to show surface label, similar to the 
labeling of dissociated, live, unfixed cells (not shown). 
We observed little change in the overall pattern of FORSE-1 
staining after acetone fixation at any age except from E 11 .5 to 
E13.5. At El 5, acetone fixation results in an intensification of 
telencephalic staining, as well as minor areas of diencephalic 
staining (Fig. 3). From El 1.5 to El3.5, however, acetone fixation 
enables us to visualize FORSE-1 staining in a restricted part of 
the dorsal half of the entire CNS, from midbrain to the caudal-
most spinal cord (Fig. 7). The dorsalmost area of the neural tube 
was consistently negative, as was the entire ventral half, result-
ing in a dorsoventrally restricted band of FORSE-1 staining. 
When the FORSE-1 mAb is diluted, however, the forebrain 
staining remains while, with increasing dilution, the spinal cord 
and then the midbrain and hindbrain staining become undetect-
able, even after acetone fixation (Fig. 7). This dilution result 
suggests a gradient of FORSE- 1 antigen expression from high 
in the forebrain to low in the spinal cord. Such a gradient is 
supported by immunoblots of subdivisions of the CNS at E12 
(see Fig. 9 and following section). Acetone may modify the 
FORSE-1 epitope, resulting in better binding of the mAb, or 
allow the mAb improved access to the epitope. 
Identification of the FORSE-1 antigens 
To identify the FORSE-1 antigen, forebrains from El5 rat em-
bryos were homogenized in low salt, and soluble and membrane 
fractions were separated by centrifugation. When the proteins in 
these two fractions were subjected to immunoblot analysis, 
FORSE-1 is found to bind a high-molecular-weight region, in 
both soluble and membrane-bound forebrain fractions, which 
does not migrate out of the stacking portion of the gel (Fig. SA). 
There is no obvious staining of any proteins present within these 
two fractions when FORSE-1 is omitted from the incubation, 
and·a variety of other antibodies generated from the same fusion 
do not label the high-molecular-weight region labeled by 
FORSE-1 (not shown). The heterogeneous and very large size 
of the FORSE-1-positive band suggest that the antigen is pro-
teoglycan like (Herndon- and Lander, 1990; Fryer et al, 1992; 
Maeda et al., 1992). 
The nature of the FORSE-1 antigen in older animals was de-
termined by performing immunoblots using protein fractions iso-
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Figure 8. FORSE-1 and 52G9 both recognize a proteoglycan in the 
embryonic and newborn rat forebrain, and regionally expressed 80 kDa 
doublets in the adult CNS. Soluble (s) and membrane/cytoskeletal (p) 
protein preparations from E15 and PO rat forebrains, as well as mem-
brane/cytoskeletal fractions (p) of adult rat cerebrum (cbr), cerebellum 
(cbl), and spinal cord (sp c), were subjected to SDS-PAGE and im-
munoblQt analysis. A shows the binding of mAb FORSE-1 to a proteo-
glycan in the embryonic and PO forebrain, and to 80 kDa doublets in 
the adult rat crb. cbl, and sp c. B shows very similar binding of mAb 
5209 to essentially identical nitrocellulose transfers. Primary antibody 
binding was visualized with a peroxidase-conjugated goat anti-mouse 
IgM secondary antibody. Arrowhead represents border between stack-
ing and running gels. 
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lated from newborn (PO) forebrains and subregions of the adult 
CNS. While FORSE-1 binds similar high-molecular-weight 
regions in the soluble and membrane-bound fractions of the PO 
forebrain, this labeling is completely absent in any of the adult 
brain fractions (Fig. 8A ). FORSE-1 does, however, specifically 
label a doublet centered at about 80 kDa in the membrane-
bound, but not the soluble (not shown), fractions derived from 
the adult cerebrum and spinal cord, and a similar doublet that 
migrates slightly faster than 80 kDa in the membrane fraction 
derived from the adult cerebellum (Fig. 8A). The adult antigens 
are likely to be integral membrane proteins as they are fully 
extracted from the membrane fractions by Triton X-100 and 
NP40 (not shown). These bands are not labeled when FORSE-1 
is omitted from the incubation, nor are they stained by a variety 
of other antibodies generated in the same fusion (not shown). 
Consistent with our immunohistochemical results, there is no 
obvious binding to soluble or membrane-bound fractions derived 
from the following adult tissues: dorsal root ganglia, sciatic 
nerve, kidney, liver, and adrenal medulla (not shown). We also 
performed irnmunoblots using 52G9, a previously characterized 
mAb that labels the forebrain of rat embryos (Stainier et al. , 
1991). Surprisingly, we find these immunoblots (Fig. 8B) are 
essentially identical to those generated with FORSE-1 (Fig. 8A ). 
Moreover, in the immunoblot analyses of the rostrocaudal dis-
tribution of the embryonic/PO antigen, and the carbohydrate con-
tent of both the embryonic/PO and adult antigens using 
FORSE-1 described below, identical results were obtained with 
52G9 (not shown). 
A stringent test of whether the high-molecular-weight, 
FORSE-1-immunoreactive species is, in fact, the antigen visu-
alized immunohistochemically in the embryo, is to analyu its 
rostrocaudal distribution. To do this we generated soluble and 
membrane-bound fractions from El2.5 and EIS forebrain, mid-
brain and hindbrain, spinal cord, and body (minus spinal cord). 
Equal amounts of protein from each fraction were subjected to 
an immunoblot analysis using FORSE-1. At both these ages, the 
biochemically detected rostrocaudal difference in the distribution 
of the FORSE-1 epitope parallels the immunohistochemical re-
sults (Fig. 9A). In addition, FORSE-1 detects similar levels of 
the embryonic antigen in protein fractions derived from PO fore-
brain, cerebellum, and spinal cord (Fig. 9B), consistent with the 
lack of an immunohistochemical rostrocaudal gradient at this 
age. These data taken together indicate that the embryonic 
FORSE-1 epitope most likely resides on a high-molecular-
weight, proteoglycan-like antigen. 
The proteoglycan-like characteristics of the embryonic/PO an-
tigen prompted us to determine whether the FORSE-1 epitope 
is composed of amino acids or carbohydrate. To do this we di-
gested soluble fractions of PO rat forebrain with the following 
glycosidases: chondroitinase ABC, hyaluronidase, heparitinase, 
keratinase, endoglycosidase-H, neuraminidase, or N-glycosidase 
F, and performed an immunoblot analysis using mAb FORSE-
1. Chondroitinase ABC digestion yields a more tightly resolved, 
faster migrating (although still within the stacking gel) FORSE-
1-immunoreactive species (Fig. 10). None of the other glycosi-
dases affected the mobility of the antigen or the binding of mAb 
FORSE-1 (not shown). This result suggests that the embryonic/ 
PO antigen is a proteoglycan that contains chondroitin sulfate. 
The migration (highly resolved bands) and nonionic detergent 
extract.ability of the adult antigens are not proteoglycan like, but 
are rather suggestive of a membrane glycoprotein. To test this 
we digested membrane fractions of adult rat cerebellum (solu-
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Figure 9. The FORSE-I epitope on the proteoglycan is enriched in 
the rostral CNS early in embryonic development. Soluble (s) and mem-
brane/cytoskeletal (p) protein fractions generated from various rostro-
caudal regions of the EI2.5 and EI5, as well as the PO CNS, were 
subjected to SDS-PAGE and immunoblot analysis. In A, the top panel 
shows the binding of FORSE- 1 to the proteoglycan in the El2.5 protein 
fractions, while the bottom panel shows the binding to the El5 fractions. 
Both immunoblots show that the expression of the FORSE-1 epitope 
on the proteoglycan is enriched in the forebrain. Primary antibody bind-
ing was visualized with a peroxidase-conjugated goat anri-mouse IgM 
secondary antibody. B shows the binding of FORSE-1 to fractions of 
PO rat CNS. Similar levels of the proteoglycan are detected in soluble 
as well as membrane/cytoskeletal fractions. 
bilized with I% NP40) with the same glycosidases used to char-
acterize the embryonic antigen, and performed an immunoblot 
analysis with FORSE-1. While N-glycosidase F completely 
abolishes the binding of FORSE-1 , none of the other glycosi-
dases affect the mobility of the adult cerebellar antigen or the 
binding of FORSE-1 (Fig. 1 O; not shown). Identical results were 
obtained using adult cerebrum and spinal cord membranes (not 
shown). In all cases, FORSE-1 binding was eliminated whether 
the solubilized membranes were digested prior to SDS-PAGE or 
whether the nitrocellulose transfers of the resolved proteins were 
incubated with N-glycosidase F prior to the addition of the mAb 
(not shown). These data suggest that the adult antigens are gly-
coproteins that contain N -Li nked high mannose, most likely in 
the form of hybrid and complex chains, and that the FORSE-1 
epitope present on these antigens is composed of carbohydrate. 
Comparison with mAb 52G9 
We compared the immonohistochemical labeling pattern of 
FORSE-1 with that of 52G9 (Stainier et al., 1991). At all ages, 
consistent with the results of the immunoblot analysis (see 
above), the binding patterns of the two mAbs are identical, in-
cluding the restricted labeling of the CNS (Fig. 3), nasal epithe-
lia, and otic struc tures. Taken together, the immunohistochemical 
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Figure JO. The FORSE-1 epitope is composed of carbohydrate. A. 
Equal amounts of soluble protein derived from the PO rat forebrain were 
digested wi th chondroitinase ABC as described in the Materials and 
Methods. These digests, along with an undigested sample containing 
the same amount of protein, were subjected to SOS-PAGE and immu-
noblot analysis. FORSE-1 binds the proteoglycan in the control, undi-
gested sample (-), and to a more resolved, faster migrating species in 
the sample digested with chondroitinase ABC (CH). 8, A membrane/ 
cytoskeletal fraction derived from the adult rat cerebellum. solubilized 
with 1 % NP40, was digested with N-glycosidase F (N-GL) as described 
in the Materials and Methods. This digest and an undigested sample of 
the same protein fraction were subjected to SDS-PAGE and immunoblot 
analysis. N-glycosidase F completely eliminates the binding of mAb 
FORSE-1 to the 80 k.Da doublet. The upper arrow indicates the border 
between the stacking and running gels for both A and 8. Primary an-
tibody binding was visualiz.ed with a peroxidase-conjugated goat anti-
mouse IgM secondary antibody. 
and immunoblot data indicate that FORSE- L and 52G9 recog-
nize epitopes on the same embryonic and adult antigens. 
Discussion 
Developmental expression of the FORSE-1 epitope in the CNS 
From the earliest stages, prior to closure of the neural tube, the 
FORSE-1 mAb exhibits a posit ionally restricted pattern of bind-
ing in the CNS. This suggests that the FORSE-1 antigens could 
play a role in patterning the neural tube. To understand the spa-
tial regulation of the FORSE- 1 antigens, the important features 
of the staining pattern are discussed separately below, and the 
data is summarized in Figure I I. 
Proliferative neuroepithelium staining (E9.5- E/7.5). That 
cells of dividing neuroepithelium specifically label with 
FORSE-1 is well demonstrated at E 17 .5 (Fig. 4), where staining 
is seen in cells of the ventricular zone but not the cortical plate. 
Regional specificity in the El 1.5-E/3.5 Jorebrain. The fore-
brain contains some FORSE- 1-positive and some FORSE-1-neg-
ative areas. From El 1.5 to E 13.5, the basal telencephalon and 
the lateral walls of the telencephalic bulbs label with FORSE-1 
while the medial walls do not, and the boundaries between the 
positive and negative regions are sharp. In the diencephalon, 
FORSE- 1 displays a unique labeling pattern which we have 
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Figure 11. FORSE-1 labeling in the developing CNS. Hatching rep-
resents FORSE-1 staining, with greater densities reflecting higher la-
beling intensities. In the El l-E14 diencephalon, the three stripes of 
hatching represent the regional restriction described in Figure 2. In the 
E 11-E 14 midbrain, hindbrain, and spinal cord, the restricted region of 
hatching represents the staining observed in transverse sections, visu-
alized after acetone fixation, as described in Figure 8. 
compared in detail to several transcription factors ('Ible and Pat-
terson, 1995). The FORSE-1 labeling pattern is not identical to 
any of the known transcription factors in the early forebrain, and 
serves to further subdivide the developing forebrain. 
Dorsoventral restriction in the midbrain-hindbrain-cord 
(Ell .5-El 3.5 ). Dorso ventral restriction within the fore brain is 
discussed above. Acetone fixation reveals a dorsoventrally re-
stricted region of FORSE-1 labeling along the entire rostrocau-
dal extent of the CNS, from El 1.5 to E13.5. This FORSE-1-
positive region lies in between a small dorsalmost area that is 
FORSE-1 negative, and most of the ventral half of the CNS. 
Transcription factors Pax3 and 7 have similar dorsoventrally re-
stricted distributions; Pax6, in contrast, appears to have a com-
plementary distribution to that of FORSE-1 in the spinal cord. 
Members of the HoxB family all display spatially and tempo-
rally regulated patterns along the dorsoventral axis and show a 
striking dorsal restriction in the spinal cord between El2.5 and 
E14.5 in the mouse (Graham et al., 1991). Graham et al. suggest 
that the dynamic pattern of expression of these genes could re-
flect their role in conferring rostrocaudal identity to different 
classes of neurons as they are born in different locations along 
the dorsoventral axis. Dbx-1 is expressed in a narrow, dorso-
ventrally restricted stripe in the embryonic spinal cord (Lu et 
al., 1992), and MASH- I is transiently expressed in a dorsal re-
gion of the ventricular zone in the embryonic spinal cord (Lo et 
al., 1991 ). All these expression patterns reveal molecular differ-
ences in cells based on their dorsoventral position. 
Widespread labeling of mature neurons (£18-adult). From 
late embryonic life through adulthood, the FORSE-1 antigen ap-
pears to no longer be subject to the spatial regulation discussed 
above. Instead, neurons throughout the CNS express the antigen, 
with local variations in intensity of labeling. This is consistent 
with the possibility that the FORSE-1 antigen has different roles 
in embryonic life and in maturity. The rostrocaudal regulation 
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discussed above and the expression pattern from late embryonic 
life to adulthood together are reminiscent of the biphasic ex-
pression pattern of NCAM in the developing mouse CNS (Bally-
Cuif et al., 1993). NCAM is first expressed in a rostrocaudal, 
position-dependent pattern, and then is expressed by almost all 
postmitotic neurons. It is significant that throughout embryonic 
and early postnatal life, the FORSE-1 antigen identified in the 
CNS is a high-molecular-weight proteoglycan (discussed further 
below), indicating that the change in expression pattern from a 
restricted to a widespread one does not appear to be accompa-
nied by a change in the identity of the antigen. In the adult, 
however, FORSE-1 binds an 80 kDa doublet. 
FORSE-1 antigens 
FORSE-1 recognizes an epitope on apparently distinct bands on 
immunoblots, and these are regulated with different develop-
mental time courses. From E 12.5 through early postnatal life, 
FORSE-1 binds a high-molecular-weight antigen in soluble and 
membrane-bound forebrain fractions that does not migrate out 
of the stacking gel even when subjected to SDS-PAGE under 
reducing conditions. A number of properties of this antigen in-
dicate that it is likely to be a proteoglycan (Zaremba et al., 
1989). The estimated molecular weight (>200 kDa) of the 
FORSE-1-immunoreactive species and its broad, diffuse migra-
tion pattern are consistent with this antigen being a proteogly-
can. The most compelling evidence on this point is provided by 
enzymatic digestion. That chondroitinase ABC digestion of sol-
uble and membrane-bound forebrain fractions results in a tighter 
FORSE-1-positive band that migrates faster on SDS-PAGE 
strongly suggests that this antigen is a proteoglycan that contains 
chondroitin sulfate. The presence of the FORSE-1-immunoreac-
tive proteoglycan in soluble as well as membrane-bound fore-
brain fractions is consistent with other studies that describe a 
similar subcellular distribution of proteoglycans (Zaremba et al., 
1989; Oohira et al., 1988; Herndon and Lander, 1990; Maeda et 
al., 1992). 
A number of recent studies have described the expression of 
developmentally regulated proteoglycans in the mammalian 
CNS (Herndon and Lander, 1990; Streit et al., 1990; Cole and 
McCabe, 1991; Fryer et al., 1992; Maeda et al., 1992), but none 
have reported a proteoglycan epitope whose expression is pos-
itionally and developmentally regulated as in the present case. 
That the biochemistry accurately reflects the distribution of the 
antigen detected immunohistochemically is especially clear at 
El2.5 and EIS, where, consistent with the immunohistochem-
istry, immunoblot analysis clearly shows a forebrain-enriched 
distribution of the proteoglycan bearing the FORSE-1 epitope. 
During early postnatal development, in contrast, FORSE-1 labels 
sections of rostral and caudal CNS equally, and immunoblot 
analysis detects no positional difference in the expression of the 
proteoglycan. These results strongly suggest that we have cor-
rectly identified the antigen bearing the FORSE-1 epitope. 
In immunoblots of membrane-bound fractions derived from 
the adult brain and spinal cord, FORSE-1 binds a doublet of 
proteins centered at about 80 kDa. These FORSE-1 antigens 
appear to be integral membrane glycoproteins and not proteo-
glycans, because they are completely solubilized by nonionic 
detergents, their mobility is not affected by enzymes such as 
chondroitinase ABC, and N-glycosidase F treatment removes the 
FORSE-1 cpitope. The latter result suggests that these antigens 
contain N-linked high mannose oligosaccharides, most likely in 
the form of hybrid and complex chains, and further indicates 
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that the epitope recognized by FORSE-1 is composed of car-
bohydrate. This suggests that the FORSE-1 epitope on the em-
bryonic antigen also contains N-linked high mannose oligosac-
charides. However, N-glycosidase F treatment does not remove 
the epitope on the embryonic antigen, perhaps due to the en-
zyme's inability to access the appropriate site. This epitope is 
CNS specific as it is not present in the PNS or in a variety of 
non-neuronal tissues. In addition, the size of the doublet, at least 
in the adult, is region specific. The forebrain and spinal cord 
express a doublet centered at about 80 kDa, while the molecular 
weight of the doublet in the cerebellum is slightly smaller. This 
size disparity could be due to the presence of additional carbo-
hydrate on the forebrain/spinal cord proteins. It is also possible 
that the core proteins in each doublet are distinct. Several such 
region-specific carbohydrate-bearing antigens have been shown 
to be expressed during the early development of Drosophila, 
grasshopper (Snow et al., 1987), rat (Dodd et al., 1988), and 
chick (Canning and Stem, 1988; Roberts et al., 1991). 
Comparison with mAb 52G9 
As described in the Results, we find that mAb FORSE-1 and 
mAb 52G9 have identical labeling patterns in our hands. Some 
of our findings, like the staining of the telencephalon, olfactory 
bulb, nasal pits, otic placodes, and Rathke's pouch, agree with 
those of Stainier et al. (1991). Our other results, particularly the 
biochemical characterization of the antigen, the pattern of la-
beling in the forebrain, the transient, dorsoventrally restricted 
labeling of the entire CNS, and the presence of staining at E18 
and beyond, are very different from· those previously reported 
for mAb 52G9. We do not, at any age, observe a single, restrict-
ed region of labeling in the diencephalon as was reported for 
mAb 52G9. Rather, this restricted region is part of the pattern 
we demonstrate in the diencephalon from El 1.5 to E13.5 (Fig. 
2C), which is clearly visualized in horizontal sections. Stainier 
et al. used sagittal sections, which do not permit visualization 
of each of the regions in a single section. Moreover, despite 
many variations in our methods, and replication of the methods 
of Stainier et al., neither mAb yields the 55 kDa band on im-
munoblots of El5 forebrain that was reported by them. 
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